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ABSTRACT
Base excision repair (BER) represents the most im-
portant repair pathway of endogenous DNA lesions.
Initially, a base damage is recognized, excised and
a DNA single-strand break (SSB) intermediate
forms. The SSB is then ligated, a process that
employs proteins also involved in SSB repair, e.g.
XRCC1, Ligase III and possibly PARP1. Here, we
confirm the role of XRCC1 and PARP in direct SSB
repair. Interestingly, we uncover a synthetic lethality
between XRCC1 deficiency and PARP inhibition. We
also treated cells with alkylating agent dimethyl
sulfate (DMS) and monitored the SSB intermediates
formed during BER. DMS-induced SSBs were
quickly repaired in wild-type cells; while a rapid ac-
cumulation of SSBs was observed in cells where
post-incision repair was blocked by a PARP inhibitor
or by XRCC1 deficiency (EM9 cells). Interestingly,
DMS-induced SSBs did not accumulate in PARP1
siRNA depleted cells, demonstrating that PARP1 is
not required for efficient completion of BER. Based
on these results we suggest no immediate role
for PARP1 in BER, but that PARP inhibitors trap
PARP on the SSB intermediate formed during BER.
Unexpectedly, addition of PARP inhibitor 2h after
DMS treatment still increased SSB levels indicating
ongoing repair even at this late time point.
INTRODUCTION
Base damages, such as methylations, oxidations,
depurinations and single-strand breaks (SSBs) are
commonly formed by endogenous cellular metabolism
(1). The recognition of these damages is imperative for
efﬁcient repair and is achieved by a set of specialized
glycosylases. Poly(ADP-ribose)polymerase 1 (PARP1) is
an evolutionary poorly conserved nick-sensing enzyme
with the catalytic ability to produce long polymers of
ADP-ribose on itself and other proteins (2). This polymer-
ization is stimulated by the binding of PARP1 to a nick in
the DNA and results in the rapid relocation of repair
proteins such as XRCC1, to the site of the lesion (3).
PARP1 is known to interact with proteins in both short-
and long-patch repair pathways downstream of damage
recognition (4–7). Precisely how PARP1 functions in
repair and signalling is not yet determined as its main
activity at the DNA SSB appears to be autoribosylation,
which is ﬁnalised when the negatively charged ADP-ribose
polymers cause PARP1 to dissociate from the DNA.
Inhibition of PARP1 has been shown to impair DNA
SSB repair, as the inhibition of its polymeric activity
traps the enzyme at the SSB and physically blocks
further repair (8). However, PARP1 does not appear to
be required for SSB repair as cells with PARP1 knocked
down still display efﬁcient SSB repair activity (8). The
binding of PARP1 to SSBs may act as protection from
excessive DNA damage by sequestering the potentially
toxic intermediates until they can be repaired. Although
PARP1 is often annotated to be a base excision repair
(BER) protein it is unclear exactly how and if PARP1 is
involved in the repair of DNA lesions such as methylated
or oxidizes bases. Here, we hypothesize that PARP1 has
no active role in BER, since it is a poorly conserved
protein through evolution, in contrast to many other
BER factors. Furthermore, the aim of this study is to
assay SSB formation to enable us to investigate the
impact of PARP1 in the repair of methylated DNA and
to investigate how PARP inhibition and knockdown can
affect this process.
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Cell cultures
Cells were cultured at 37 C in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 9% fetal calf serum
and penicillin-streptomycin (90 units/ml) in an atmos-
phere containing 5% CO2. The cell lines used in this
study were human alveolar basal epithelial cell line A549
and the XRCC1-deﬁcient Chinese hamster ovary (CHO)
cell line EM9, the latter stably transfected with either
empty vector (EM9-V) or his-tagged XRCC1 gene
(EM9-XH) as described in (9).
siRNA transfection
About 1 10
6 cells were seeded in a 75 cm
2 ﬂask and
cultured for 24h before transfection with siRNA.
Transfection (10nM siRNA) was performed using
INTERFERin
TM (PolyPlus Transfection) according to
the vendor’s protocol. The siRNA was purchased from
MWG Biotech AG with the oligosequences: PARP1;
50-AAGCCAUGGUGGAGUAUGATT-30 and MPG;
50-AAGAAGCAGCGACCAGCUAGA-30.
Repair assay
Cells were seeded in 24-well plates, at a density of 5 10
4
cells per well, and cultured for 24h before labelling
the DNA with
3H-TdR (7.1 kBq/ml) for 24h. To ensure
a low background of SSBs, the cells were washed twice
with HBSS
+ + and incubated in fresh DMEM for 1h.
Treatment with hydrogen peroxide (H2O2) or dimethyl
sulfate (DMS) (diluted in HBSS
+ +) was performed for
15min on ice and was terminated by washing the cells
with ice cold HBSS
+ + twice. Although BER is not com-
pletely abolished, the incision rate is reduced  20-fold by
a temperature shift from 37 Ct o4  C (10). Pre-warmed
DMEM was added to the cells, which were then incubated
at 37 C for various time intervals to monitor the repair.
Treatment with DNA damaging agent and the follow-
ing steps were performed in the presence of PARP inhibi-
tor 1,8-napthalimide (50mM) in speciﬁed samples (11).
In order to study remaining damages, the pre-warmed
DMEM was replaced by pre-warmed DMEM contain-
ing 1,8- napthalimide (50mM), as indicated, 2h after
terminating the treatment with DMS.
In the ADU (alkaline DNA unwinding) assay the cells
were washed twice with ice cold 0.15M NaCl and lysed in
the DNA unwinding solution (0.15M NaCl, 30mM
NaOH) on ice, with the exception of the experiments
done with A549 cells and the DMS dose-curve, in which
the unwinding was performed at room temperature. The
unwinding of DNA was continued for 30min in darkness
and was subsequently neutralized by the addition of
20mM NaH2PO4. The DNA was then fragmented by son-
ication (15sec, Branson soniﬁer B-12, with micro tip),
after which SDS (ﬁnal concentration of 0.24 %) was
added. The samples were kept frozen for at least 12h at
 20 C. Separation of double-stranded (ds) and single-
stranded (ss) DNA was performed on hydroxyl apatite
columns, kept at 60 C, as described earlier (12). Brieﬂy,
cell lysates were diluted with water (dilution factor 0.4)
and 1ml of each sample was loaded on to a column.
The bound DNA was washed with sodium phosphate
(10mM) and ssDNA was eluted with 4.25ml potassium
phosphate at a concentration of 0.1M, where after
dsDNA was eluted with 4.25ml potassium phosphate at
a concentration of 0.25M. The number of SSBs per cell
was calculated from the ratio of ssDNA to dsDNA by
correlation with a standard curve obtained by
g-irradiation (12–14).
Survival assay
Cells were seeded in 10cm Petri dishes 6–8h prior to treat-
ment. Exposure to hydrogen peroxide (H2O2) or DMS
was performed for 15min on ice in HBSS
+ +, after which
the cells were washed and DMEM was added. Exposure
to 1,8-napthalimide was performed by the addition of
inhibitor to the cellular growth medium  6h after
seeding the cells. After 24h the medium was replaced
with fresh DMEM. The plates were incubated at 37 C
under 5% CO2. After 7–10 days, the colonies were
ﬁxed, stained (methylene blue dissolved in methanol,
4g/l) and counted. Calculations are based on the mean
value of two replicas per treatment in three separate
experiments.
Western blot analysis
Cells were trypsinized and washed with HBSS
 + before
the addition of protein lysis buffer (1  protease inhibitor
cocktail Roche, 1 % NP-40, 150mM NaCl, 0.1M Tris pH
8.0). Whole cell lysates were prepared by 30min lysis on
ice with vortexing every 5min followed by centrifugation,
where the pellet was discarded. The protein concentration
was determined by the Bradford assay (Hercules, CA) ac-
cording to the vendor’s protocol. The lysates (75mg
protein) were resolved by 4–12% NuPAGE Bis-Tris Gel
(Invitrogen) for subsequent western blot analysis using
antibodies against the following proteins diluted in 5 %
milk (in PBS) as indicated: b-tubulin (1:500), PARP1
(1:500) and MPG (HPA006531, Atlas Antibodies AB)
(1:500). The gel was transferred to a nitrocellulose
membrane and immunoblotted with primary antibody.
The secondary antibody (anti-mouse or anti-rabbit) IgG
conjugated to horseradish peroxidase was used for detec-
tion of the proteins by an ECL western blot detection
system (Thermo scientiﬁc).
RESULTS
Distinct roles of XRCC1 and PARP inhibition in SSB
repair
It is well established that both PARP1 and XRCC1 are
involved in DNA SSB repair (15,16), and that
poly(ADPribose) synthesis is required for the recruitment
of XRCC1 to sites of oxidative DNA damage (3). To
conﬁrm and further investigate the functions of these
proteins in SSB repair, we determined the survival and
SSB repair capacity in response to hydrogen peroxide in
XRCC1 defective EM9 cells stably transfected with empty
vector (EM9-V) or wild-type XRCC1 (EM9-XH) in the
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found that both XRCC1 deﬁciency as well as co-treatment
with PARP inhibitor sensitizes cells to hydrogen peroxide
(Figure 1A). Interestingly, we report that XRCC1 defect-
ive EM9-V cells are hypersensitive to PARP inhibitors
alone (Figure 1B). In order to investigate whether this
hypersensitivity is due to the functions of PARP and
XRCC1 in SSB repair, we measured the background
level of SSBs in these cells. To allow for a direct and
quantitative measurement of the number of SSBs we
employed the ADU technique (13,14,17), and we found
no correlation with the background levels of SSBs and the
presence of XRCC1 or the addition of a PARP inhibitor
(Figures 1C and 6B).
When monitoring SSB repair by measuring the level of
SSBs in cells over time after H2O2-induced damage, we
found that PARP inhibition reduce the rate of SSB rejoin-
ing (Figure 1D), which support previous results obtained
with the comet assay (15). Also, we conﬁrmed that the
level of SSBs is considerably enhanced in the cell line
lacking XRCC1, indicating impaired ligation of breaks
(Figure 1E). PARP inhibition in these cells had an add-
itional decelerating effect on the rate of ligation, further
indicating distinct roles of the two proteins in SSB repair.
Figure 1. PARP1 and XRCC1 have distinct roles in efﬁcient SSB repair. The PARP1 and XRCC1 proteins are involved in DNA repair in response
to hydrogen peroxide. (A) Survival, following a 15min exposure to hydrogen peroxide on ice, of XRCC1 deﬁcient EM9 cells expressing wild-type
XRCC1 (EM9-XH) or empty vector (EM9-V). Cells were treated in the presence or absence of PARP inhibitor (1,8-napthalimide, 50mM), which was
left in the growth medium for 24h after treatment. Survival is plotted as percentage of living mock treated cells without PARP inhibition. The means
and standard errors of three experiments are shown. (B) XRCC1 defective EM9-V cells are hypersensitive to PARP inhibitors alone. Survival of
EM9-XH and EM9-V cells, following a 24h treatment with PARP inhibitor under normal growth conditions. The means and standard errors of
three experiments are shown. (C) Background levels of SSBs in EM9-V or EM9-XH cell lines, measured after various time points of incubation with
or without PARP inhibitor (50mM). The means and standard errors of three experiments are shown. SSB repair rates in the cell lines EM9-XH
(D) and EM9-V (E) after a 15min treatment with 200mM hydrogen peroxide. Dotted lines indicate the levels of SSBs in mock treated cells for each
cell line. Cells were treated and left to repair in the presence or absence of PARP inhibitor. The means and standard errors of three experiments are
shown.
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alkylated DNA lesions
DMS is used in these experiments since it is 25–30 times
more potent than methyl methanesulfonate (MMS) but
will produce similar proportions of methylated DNA
products (18). DMS will thus remain active on ice, as
opposed to MMS. By exposing cells to DMS on ice, we
ensure that a minimal background repair is operating
during treatment and we can investigate whether
XRCC1 and PARP have additional roles in BER, as
opposed to their known functions in SSB repair
(Figure 2A).
We found that SSBs rapidly accumulate in EM9-V cells
after DMS treatment (Figure 2B) suggesting that the de-
tection and excision of methylated bases is independent of
XRCC1. The ADU technique might not fully distinguish
between AP-sites and SSBs formed during repair, so we
cannot specify if the same is true for BER incisions.
Furthermore, the accumulation of SSBs highlights the im-
portance of the XRCC1–LigIIIa complex in the latter
ligation step of both BER and SSB repair (19). In the
SSB assay performed here we also observed a dramatic
increase in the level of SSBs following DMS treatment
in PARP inhibited cells (Figure 2C). Additionally, when
impeding both proteins simultaneously by inhibiting
PARP in XRCC1 deﬁcient cells we detected higher levels
of SSBs than if either protein is incapacitated alone. The
lack of XRCC1 sensitized cells to alkylating damage on
the DNA, in a similar fashion as PARP inhibition
(Figure 2D), suggesting that these proteins play a role in
the repair of DMS lesions. The decreased survival in
EM9-V cells treated with PARP inhibitor is most likely
due to the hypersensitivity mentioned earlier (Figure 1B).
The low levels of SSBs detected in wild-type cells after
treatment with DMS indicate a very fast and efﬁcient
repair of alkylating damages to the DNA. To determine
Figure 2. Distinct roles of XRCC1 and PARP inhibition in BER. (A) To study SSB formation during BER, cells were seeded 24h prior to labelling
the DNA with
3H-TdR for an additional 24h. Exposure to DMS was performed on ice to reduce repair during treatment, where after DNA repair
was induced by raising the temperature to 37 C for various time intervals. The amount of strand breaks was measured by the alkaline DNA
unwinding technique (12). BER incision and formation of a SSB is independent of XRCC1 in cells. Levels of SSBs in the EM9-V and EM9-XH cell
lines after a 15min treatment with 0.5mM DMS at indicated time points of repair. Cells were treated and left to repair in the (B) absence or
(C) presence of PARP inhibitor. The means and standard errors of three experiments are shown. (D) Survival, following a 15min exposure to DMS
on ice, of XRCC1 deﬁcient EM9-V cells expressing empty vector (EM9-V) or wild-type XRCC1 (EM9-XH). Cells were treated in the presence or
absence of PARP inhibitor, which was left in the growth medium for 24h after treatment. Survival is plotted as percentage of living mock treated
cells without PARP inhibition. The means and standard errors of three experiments are shown.
Nucleic Acids Research,2011, Vol.39, No. 8 3169the repair capacity of CHO cells we treated EM9-XH and
EM9-V cells with increasing doses of DMS and left them
to repair for 15min (Figure 3). We found that there is a
dose-dependent increase of SSBs, suggesting that the
amount of damage to the DNA, at the doses of DMS
used in this study, is not saturating the engaged repair
pathways.
MPG is required for BER initiation after DMS-induced
lesions in cells
In order to ascertain that the induced SSBs observed after
DMS treatment represent damages processed by BER
and not direct SSBs, we siRNA depleted the glycosylase
MPG in A549 cells and determined the efﬁciency of
the MPG knockdown (MPG
KD) by western blotting
(Figure 4A). Subsequently, we followed the SSB formation
in MPG
KD cells after DMS treatment and found that
MPG
KD cells exhibited SSBs at background level through-
out the time of repair (Figure 4B), in contrast to cells with
functional MPG. A similar differential effect was seen
when both DMS treatment and the following repair were
carried out in the presence of a PARP inhibitor, indicating
that the majority of SSBs produced after DMS treatment
arise from MPG-dependent removal of methylated bases.
BER kinetics is unaffected in PARP1 knockdown cells
We found that PARP inhibition efﬁciently disrupts BER
(Figures 2 and 4). This could be due to an essential role of
PARP1 in the latter steps of BER ligation (20) e.g. because
PARP inhibitors will block the release of PARP1 from the
SSB intermediate it is supposed to protect. To test this we
siRNA depleted PARP1 in A549 cells and determined the
efﬁciency of the PARP1 knockdown (PARP1
KD)b y
western blotting (Figure 5A). We followed the repair of
SSBs in PARP1
KD cells after DMS treatment and found
that PARP1
KD cells exhibited a slightly lower amount of
SSBs after DMS treatment than wild-type A549 cells
(Figure 5B), indicating that PARP1 is in fact not necessary
for ligation. Interestingly, the overall SSB levels in
PARP1
KD cells were slightly closer to background
compared to wild-type A549 cells after DMS treatment.
Next, we followed the SSB levels in A549 and PARP1
KD
cells exposed to DMS and incubated in the presence of
the PARP inhibitor. We found an accumulation of
SSBs in the wild-type cells but not in the PARP1
KD cells
(Figure 5C). Also, the overall background levels were
increased following addition of a PARP inhibitor in
DMS treated cells, which in speculation could reﬂect the
role of PARP2 in BER or residual PARP1 protein in these
cells.
BER continues for at least 2h after the induction of
alkylation lesions
Finally, we wanted to investigate the kinetics of BER and
analyze remaining repair when a large portion of the
alkylated DNA has already been repaired. To this end
we treated EM9-XH cells with DMS (2mM) for 15min
on ice as described, washed the cells thoroughly, and
investigated the level of SSBs during repair. We found
that the level of SSBs increases signiﬁcantly when adding
a PARP inhibitor 2h after the DMS treatment is
terminated (Figure 6A). Control experiments with un-
treated cells showed that the amount of SSBs visualized
after addition of the PARP inhibitor does not reﬂect
endogenous SSBs (Figure 6B).
We also followed the repair of SSBs in MPG
KD cells
after DMS treatment (0.5mM) and found that MPG
KD
cells exhibited background levels of SSBs which remain
low throughout the time of repair (Figure 6C), in
contrast to cells with functional MPG. Addition of a
PARP inhibitor 2 h after removal of DMS increased
SSB levels more prominently in wild-type as compared
to MPG
KD cells (Figure 6C), demonstrating that the
formation of late SSBs is dependent on active BER.
Untreated control cells did not display any change in
SSB levels, even after the addition of PARP inhibitor 2
h mock treatment is terminated (Figure 6D).
DISCUSSION
Here, we conﬁrm the importance of both XRCC1 and
PARP in the repair induced by oxidative damage to
the DNA (Figure 1A, D and E). XRCC1 is necessary
for repair after induction of oxidative damage to the
DNA, most likely by recruiting and stabilizing Ligase
IIIa (19). PARP inhibition also has a decelerating effect
on the rate of ligation, but the two proteins clearly
have distinct roles in this repair, as PARP inhibition
further delay SSB repair in XRCC1 defective cells. We
ﬁnd that more than half of the H2O2-induced SSBs are
Figure 3. DMS dose-curve of induced SSBs. SSBs were measured in
EM9-V and EM9-XH cells treated with increasing doses of DMS and
left to repair for 15min in fresh DMEM. The means and standard
errors of two experiments are shown.
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reconstituted wild-type cells (Figure 1D), showing that
this repair is a fast process. It should be noted that this
repair includes the BER of oxidized bases as well as SSB
repair, as H2O2 produces a variety of lesions to the DNA
(21). However, we see a characteristic rapid repair curve
where the majority of SSBs are present in the cells directly
after treatment and not after enzymatically-induced inci-
sions, as can be seen after treatment with DMS. Thus, we
suggest that the majority of the breaks originate from
direct SSBs.
We also ﬁnd that XRCC1 defective cells are hypersen-
sitive to PARP inhibitors (Figure 1B) in spite of the
fact that there was no statistically signiﬁcant increase of
the background levels of SSBs in these cells (Figure 1C),
suggesting that the increased sensitivity of XRCC1 defect-
ive cells to PARP inhibitors is explained by functions
of PARP1 and XRCC1 in processes apart from SSB
repair. For instance, blocked replication forks activates
PARP1 for efﬁcient restart to occur (22) and both
PARP1 and XRCC1 have been shown to have speciﬁc
roles at replication forks in S phase cells (8,22,23). In
speculation, there is a possibility that inhibition of
PARP would generate a toxic lesion at replication forks
that requires XRCC1 for repair, or vice versa. Also, it
should be noted that we have not observed any indications
of this hypersensitivity affecting the cells viability during
the short time of treatment and repair that are employed
in this study.
After conﬁrming the importance of functional XRCC1
and PARP in the repair of SSBs, we move on to compare
and evaluate the role of PARP in the repair of alkylated
DNA damages. By utilizing XRCC1 deﬁcient cells and
a PARP inhibitor, we efﬁciently block the ligation of
DNA breaks and thus we can monitor early repair
events. After DMS treatment we ﬁnd a high level of
SSBs in XRCC1 deﬁcient cells as well as in PARP in-
hibited cells, suggesting that neither XRCC1 nor PARP
are necessary for the detection or excision of alkylated
DNA damages repaired by BER (Figure 2B and C).
Additionally, we see even higher levels of SSBs when
impeding both proteins simultaneously by inhibiting
PARP in XRCC1 deﬁcient cells, leading to the conclusion
that the inhibition of PARP does not affect the repair of
DMS induced damages in the same manner as XRCC1
deﬁciency does.
We conﬁrm that the subsequent SSBs induced by DMS
predominantly originate from base alkylations, which are
detected by N-methylpurine-DNA glycosylase (MPG).
The level of SSBs is considerably reduced when MPG is
knocked down by siRNA depletion (Figure 4B).
Importantly, as no or very few SSBs are formed after
DMS treatment in MPG siRNA depleted cells, our data
demonstrate that MPG is the main (and possibly the only)
glycosylase to recognize and excise DMS-induced base
damage from DNA.
The role of PARP1 is likely to recognize SSBs or other
DNA ends in the DNA and to increase the repair. We ﬁnd
that H2O2-induced SSB repair is retarded in cells when
treated with a PARP inhibitor, as a likely consequence
of reduced recruitment of XRCC1 (8). Furthermore, we
ﬁnd that siRNA depletion of PARP1 did not affect the
amount of DMS-induced SSBs, or if anything decreased
the amount of SSBs (Figure 5B). This can be explained by
Figure 4. The glycosylase MPG is required for the formation of the majority of SSBs produced during the repair of DMS-induced damages.
(A) Western blot, probed with antibodies against MPG and loading control b-tubulin, showing the siRNA knockdown of MPG in human A549
cells. (B) Levels of SSBs in wild-type A549 cells and cells depleted of MPG, after a 15min treatment with 0.5mM DMS at indicated time points
of repair. Cells were treated and left to repair in the absence or presence of PARP inhibitor. The means and standard errors of three experiments
are shown.
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PARP1 is denoted as a BER protein, which is likely
related to previous observations that cell extracts from
PARP1
 /  cells are unable to complete the DNA synthesis
step of BER in vitro (20). However, the presence of
PARP1 is not required for effective BER in an in vitro
biochemical assay, and may even decrease the biochemical
kinetics of BER (24). So far, it has not been possible to
assign an exact function of PARP1 in BER (24), but our
data support a model where BER does not require
PARP1. This is also in line with PARP1 protein being
poorly conserved while many other BER factors are
well conserved through evolution. The model proposes
that the subset of BER SSB intermediates that become
uncoupled somewhere during the repair pathway, are
bound by PARP1 when it is present in the cell
(Figure 7). When PARP is inhibited it is thereby trapped
on these SSB intermediates, thus blocking their ligation
and causing a potentially toxic retention of SSBs in
the DNA. This would explain the increase of DMS-
induced SSBs observed following PARP inhibition. Such
trapping of PARP to SSB intermediates may explain the
high toxicity of PARP inhibitors in BRCA2 defective cells,
in contrast to the very modest toxicity of co-depletion of
BRCA2 and PARP1 (25).
There are two competing models for BER. One model
separate the BER incision and the subsequent SSB repair,
meaning that the DNA lesion would be identiﬁed twice;
ﬁrst by a glycosylase and then by PARP1 for SSB repair.
The other model suggests that the DNA lesion is only
recognized by a glycosylase and all following steps are
coordinated (Figure 7) (26–28). Since we ﬁnd no accumu-
lation of the SSB intermediate in PARP1 siRNA depleted
cells, we suggest that the DNA lesion is only identiﬁed by
glycosylases/endonucleases and that the following steps
are coordinated.
BER of DMS induced damages appears to be a fast and
efﬁcient repair pathway as the majority of the SSB inter-
mediates are incised and ligated within 30min after
exposure to the DNA damaging agent (Figures 2B, 4B
and 6A). However, we ﬁnd that a large number of repair
events (as measured by SSB formation after addition of a
Figure 5. BER kinetics is unaffected in PARP1 knockdown cells. (A) Western blot, probed with antibodies against PARP1 and loading control
b-tubulin, showing the knockdown of PARP1 using siRNA in human A549 cells. Level of SSBs in A549 cells with and without siRNA knockdown
of PARP1, after a 15min treatment with 0.5mM DMS at indicated time points of repair. Cells were treated and left to repair in the (B) absence or
(C) presence of PARP inhibitor. The means and standard errors of three experiments are shown.
3172 Nucleic Acids Research, 2011,Vol.39, No. 8PARP inhibitor) occur in the cells 2 h after DMS was
removed from the medium (Figure 6), which suggests
that there is still ongoing repair at this time. According
to our model, the repair events we detect through PARP
inhibition represents only a fraction of uncoupled SSB
intermediates, indicating that an even higher amount of
total BER events still occur in the cell at this time. We
speculate that this ongoing repair could be the result of
slow damage detection by the glycosylase, possibly
because of inaccessibility to the location of the lesion or
the complexity of the lesion. We also see a difference in
cells with siRNA depleted MPG compared to wild-type
cells, indicating that we are indeed studying actual BER
events (Figure 6D). However, it should be noted that there
is no certain way to ensure that the damages repaired after
2h are in fact original damages that were produced at the
time of treatment. There is a possibility that cellular DMS
is not removed in the washing step and that this could sit
in the cell and make damage 2.25h after initiation of the
treatment. Even in this scenario DMS hydrolyzes in
Figure 6. A substantial amount of damages are still being repaired 2h after exposure to DMS. Level of SSBs in EM9-XH cells treated with
(A) DMS (2mM) or (B) mock treated and left to repair. PARP inhibitor was added (open symbols, time point indicated by arrow) to slow
down the ligation step, 2h after treatment was terminated. The means and standard errors of three experiments are shown. The ongoing
SSB formation 2h after terminated treatment, represents MPG initiated BER events. Level of SSBs in A549 cells with or without siRNA
depleted MPG and treated with (A) DMS (0.5mM) or (B) mock treated and left to repair. PARP inhibitor was added (open symbols, time
point indicated by arrow) to slow down the ligation step, 2h after treatment was terminated. The means and standard errors of three experiments
are shown.
Nucleic Acids Research,2011, Vol.39, No. 8 3173aqueous solutions with a half life of 17min at 37 C (29),
so only 0.3% of the original DMS would remain in the
cells, even if no DMS was removed by the washing step.
Our conclusion is that it takes time for the BER machin-
ery to identify a fraction of the damaged bases to make the
incisions.
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